SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS
Clinical trials for SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS explained in plain language.
Never miss a new study
Get alerted when new SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS trials appear
Sign up with your email to follow new studies for SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can some schizophrenia patients safely reduce their medication?
Disease control Not yet recruitingThis study aims to find a safer way for stable schizophrenia patients to reduce their antipsychotic medication, as many request this but doctors lack clear guidelines. Researchers will test if a personalized approach, based on a patient's specific psychotic symptoms, makes dose r…
Matched conditions: SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for fighting Medication-Related weight gain
Disease control Not yet recruitingThis study aims to find the best way to manage weight gain caused by antipsychotic medications used for schizophrenia. Researchers will compare three approaches over 26 weeks: adding the drug dapagliflozin, adding the drug metformin, or using lifestyle changes alone. The goal is …
Matched conditions: SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS
Phase: PHASE4 • Sponsor: Sultan Qaboos University • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC